The Role of High-Density Lipoprotein Cholesterol in Stroke Risk and Outcomes: A Comparison Between Ischemic and Hemorrhagic Stroke

Abstract

The term Cerebrovascular accident (CVA) or stroke refers to an important medical condition responsible for significant mortality rates and disability in global statistics. The two fundamental types of strokes exist as ischemic and hemorrhagic disorders. The medical community considers High-Density Lipoprotein (HDL) cholesterol good cholesterol because it safeguards both heart health and brain functions. Multiple research studies show HDL might influence strokes but scientists still need to understand the specific connection between these elements.

The purpose of this research is to determine the connection between HDL cholesterol and cerebrovascular accidents by measuring its levels between patients with ischemic stroke and those with hemorrhagic stroke.

The researchers studied 120 patients organized into two distinct groups where 60 participants exhibited ischemic stroke symptoms together with 60 patients diagnosed with hemorrhagic stroke. Research investigators collected blood samples for examination of HDL cholesterol levels which examined their relationship to stroke types and their seriousness.

Patients who had an ischemic stroke revealed considerable decreases in HDL cholesterol when researchers compared them to patients who experienced hemorrhagic strokes. The research showed that both populations had stroke severity correlated negatively with HDL levels thus indicating patients with reduced HDL experienced more severe consequences.

The research shows that reduced HDL cholesterol levels increase the chance of getting ischemic stroke and reduce survival chances following a stroke.

The research examines High-Density Lipoprotein and its influence on stroke types particularly Ischemic and Hemorrhagic strokes in addition to cholesterol levels in Cerebrovascular accidents and measured HDL cholesterol concentrations.